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Significance Statement
Transcranial direct current stimulation (tDCS) is a neuromodulation procedure in which a weak electric direct
current is delivered through the brain for tens of minutes. Despite reported positive effects, the mechanisms
of tDCS stimulation are not yet well understood. Here, we examined microglial morphology in the mouse
cortex after tDCS. We find that the morphology and morphologic dynamics of microglia are altered by tDCS
in a manner dependent on adrenergic receptors, supporting the notion that (nor)adrenergic signaling is
involved in tDCS.
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Transcranial direct current stimulation (tDCS) has been reported for its beneficial effects on memory formation and
various brain disorders. While the electrophysiological readout of tDCS effects is subtle, astrocytes have been
demonstrated to elicit Ca2 elevations during tDCS in a rodent model. This study aimed to elucidate the effects
of tDCS on another major glial cell type, microglia, by histology and in vivo imaging. tDCS performed in awake
conditions induced a significant change in the pixel intensity distribution of Iba-1 immunohistochemistry, and
microglial somata were enlarged when examined 3 h after tDCS. These effects were blocked by adrenergic
receptor antagonists or in IP3R2 (inositol trisphosphate receptor type 2)-deficient mice, which lack large cytosolic
Ca2 elevations in astrocytes. No obvious changes were observed in isoflurane-anesthetized mice. Furthermore,
in vivo two-photon imaging of microglia showed a reduction of motility that was blocked by a 2-adrenergic
receptor antagonist. Our observations add support for the influence of noradrenaline in tDCS and suggest
possible interactions between microglia and astrocytes to express functional changes associated with tDCS.
Key words: iba1; in vivo ; microglia; norepinephrine; tDCS; two-photon imaging
Introduction
Noninvasive neuromodulation is a subject of intense
research because of its potential for treating patients with
neuropsychiatric and neurologic conditions. Transcranial
direct current stimulation (tDCS) is the application of a
constant and weak electric current to the brain through
the skull. Typical parameters applied in humans are 1 mA
over 30 cm2 for 10–30 min (Bikson et al., 2016). A fair
sized body of published literature suggests that tDCS has
positive effects on cognitive abilities and could be an
alternative treatment for various brain disorders (Fregni
and Pascual-Leone, 2007; Nitsche et al., 2008, 2009;
Brunoni et al., 2012; Dedoncker et al., 2016). On the other
hand, there is a notable degree of skepticism due to
mixed outcomes of tDCS experiments (Horvath et al.,
2015a,b; Jalali et al., 2017; Medina and Cason, 2017;
Kunzelmann et al., 2018; Turkakin et al., 2018). The skep-
ticism has been, in part, strengthened by a recent study
that suggested negligible tDCS-induced membrane po-
tential changes in cerebral cortical neurons (Vöröslakos
et al., 2018), implying limited involvement of neuronal
discharge as the prevalent mechanism of tDCS.
The circuit and cellular mechanisms for tDCS remain to
be understood. Glial cells represent electrically nonexcit-
able cells in the nervous system. They have been re-
garded as “support cells” for the normal function of
neurons. Among glial cell types, astrocytes and microglia
maintain the extracellular milieu by ion homeostasis and
phagocytosis, respectively. Additionally, astrocytes and
microglia have been reported to interact with neuronal
synapses (Wake et al., 2013; Araque et al., 2014). We
recently reported that astrocytic Ca2 surges occur dur-
ing tDCS in mice. Moreover, tDCS-induced astrocytic
Ca2 surges were shown to promote cortical plasticity
and have beneficial effects in a mouse model of depres-
sion (Monai et al., 2016; Monai and Hirase, 2016, 2018).
The recruitment of Ca2 activities in astrocytes has
prompted us to investigate another major glial cell type,
microglia.
Microglia are sensitive to brain tissue damage and
transform to reactive microglia on inflammation. Iba1 (ion-
ized calcium binding adaptor molecule 1) immunohisto-
chemistry (IHC) visualizes the morphology of microglia,
which is profoundly altered in reactive microglia. Follow-
ing the published observation that reported the lack of
pronounced microglial reactivity after tDCS (Monai et al.,
2016), here we investigated Iba1 IHC in detail by digital
image analysis. We report subtle, but significant effects of
tDCS in an awake condition, but not under anesthesia,
that depended on adrenergic receptors. Subsequently,
we examined microglial motility by in vivo two-photon
imaging and found that tDCS reduces microglial motility.
Materials and Methods
All animal procedures were performed in accordance
with the RIKEN animal experimental committee regula-
tions.
Animals
Adult C57BL/6J and IP3R2 (inositol trisphosphate re-
ceptor type 2) knock-out (KO) mice (Futatsugi et al., 2005)
were used for immunohistochemical experiments (male,
2–4 months old). BAC-GLT1-G-CaMP7 line 817 mice
(male, 2–5 months old; catalog #G7NG817, RIKEN BioRe-
source Research Center; resource ID: RBRC09650) were
used for transcranial macroscopic imaging of neuronal
and astrocytic Ca2 activity (Monai et al., 2016). Iba1-GFP
mice (male, 3–10 months old; Hirasawa et al., 2005) were
used for in vivo two-photon imaging of microglial mor-
phology.
Surgical procedures
Mice were deeply anesthetized with isoflurane (1.5–
2.0%), and their scalps were exposed by shaving. Each
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mouse was fixed on a stereotaxic apparatus (Narishige)
under isoflurane anesthesia. Throughout the surgery and
experiments with anesthetized mice, the body tempera-
ture was kept at 37°C with a heating blanket (BWT-100A,
Bio Research Center). After topical application of xylo-
caine ointment (2% lidocaine) on the scalp, the skull
above the sensory cortex was exposed by incision of the
scalp and temporal muscle. A custom-made chamber ring
was glued to the skull with cyanoacrylate superglue. After
the glue settled, we applied dental cement (Fuji LUTE BC,
GC Corporation; Super-Bond C&B, Sun Medical) for re-
inforcement. For two-photon imaging, the inner cavity of
the chamber ring was reinforced with additional dental
cement to secure the interface for an objective lens. Once
the chamber ring was rigidly attached, the mouse was
fixed on a custom-made stage via the chamber ring.
Thereafter, a small craniotomy (  3 mm, with intact
dura) was carefully made using a dental drill.
Habituation to head restraint
The postsurgical recovery period was at least 3 d for
IHC experiments and 2 weeks for in vivo two-photon
imaging experiments. Following the recovery period, mice
were placed on a water restriction schedule and sub-
jected to an acclimatization procedure for head restraint
(Fig. 1B). Food was given ad libitum. The acclimatization
procedure was performed for 7 d.
On day 1, each mouse was held in the experimenter’s
hands and water was given via a syringe (0.2 ml). During
handling, we let the mouse explore until it entered into a
body tube similar to the one used with the tDCS appara-
tus. If the mouse entered the body tube, we repeated the
procedure four to five times. The total handling time was
10 min for each mouse. From day 2, the mouse continued
to be acclimatized to the experimenter and apparatus with
a water reward (0.1–0.2 ml) for each entry to the body
tube. At this point, the head of the mouse was quickly
(10–20 s) fixed to the apparatus via the chamber ring
with its body in the tube. Additional water and sunflower
seeds were provided during head fixation (10–15 min).
The total amount of water given during head fixation was
1.0 ml/d. In some mice, for in vivo two-photon imaging
acclimatization was performed for 7 d.
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Figure 1. Head-restraint tDCS experiment. A, Experimental setup for tDCS. B, Experimental schedule of immunohistochemical
experiment. C, Top view of a BAC-GLT1-G7 Line 817 (G7NG817) mouse. Fluorescent Ca2 signal is transcranially observable. Signals
3 mm anterior to the anodal site (1  1 mm2 red square) are plotted from four mice (right, top traces). The bold trace on the bottom
is the mean of the four traces, and the shaded areas represent SE. The red arrowhead and line indicate the onset of tDCS. Scale bar,
1 mm. tDCS-induced Ca2 elevations were not observed in isoflurane-anesthetized mice (Extended Data Fig. 1-1).
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Transcranial DC stimulation
tDCS was applied on mice under anesthesia (2% iso-
flurane) or in awake conditions. In either condition, the
anode (stainless wire,   350 m) was placed on a
sodium chloride-based conductive gel interface (Z101BA,
NIHON-KODEN) spread over a circular area (  2 mm)
above the primary visual cortex (anteroposterior, 2.9
mm; mediolateral 2.0 mm). The cathode was connected
to the neck skin after topical application of xylocaine
ointment. DC (0.1 mA, 10 min) was applied with a custom-
made isolated constant-current supply.
Histology
After tDCS application, mice were kept for 30 min or 3
h before they were killed. After deep anesthesia by ure-
thane, they were first perfused with 0.9% NaCl and later
with fixative solution (4.0% paraformaldehyde in 0.1 M
phosphate buffer, pH 7.4). Following brain removal and
overnight postfixation in the same fixative, coronal slices
(60 m) were prepared using a microslicer (PRO 7, Do-
saka). For Iba1 staining, sections were incubated in a
buffer containing the primary antibody (Tris-buffered sa-
line with 0.1% Triton X-1000; 1:2000; catalog #019-
19741, Wako) overnight. The sections were subsequently
washed in PBS and incubated with the Cy3-conjugated
secondary antibody (Invitrogen) for 2 h for fluorescent
labeling. To evaluate DSP4 [N-(2-chloroethyl)-N-ethyl-2-
bromobenzylamine hydrochloride] efficacy, noradrenergic
fibers were labeled by anti-tyrosine hydroxylase (TH) an-
tibody (1:1000; catalog #AB152, Millipore) using sagittal
slices (60 m). For positive control of microglial reactivity,
Escherichia coli lipopolysaccharide (LPS; 0.5 mg/kg) was
administered by intraperitoneal injection 2 d before the
mice were killed.
Confocal imaging
Immunolabeled cortical microglia (V2 area) were exam-
ined using a confocal microscope (FV1000, Olympus).
Images were acquired with a 60 water-immersion ob-
jective (UPlanSApo; numerical aperture, 1.20) at an exci-
tation wavelength of 559 nm. Imaged areas covered
211.761  211.761 m2 (1024  1024 pixels) with an
optical sectioning of 0.5 m. Images were scanned with
the one-way mode (8 s/pixel exposure).
Drug administration
In some experiments, the following drugs were admin-
istered before tDCS by intraperitoneal injection: ICI81551
(5 mg/kg body weight, 30 min before; Tocris); and Prazo-
sin (10 mg/kg, 30 min before; Sigma-Aldrich). For the
ablation of noradrenergic neurons, DSP4 (Sigma-Aldrich)
was injected 11 and 7 d before tDCS application (50
mg/kg, i.p., each time). Drugs were dissolved in 0.9%
NaCl.
In vivo imaging of microglial morphology
Adult Iba1-EGFP transgenic mice (Hirasawa et al.,
2005), in which EGFP is expressed exclusively in micro-
glia, were used to monitor microglial morphologic dynam-
ics. All mice were habituated to the experimental
apparatus for 7 d. On the day of imaging, the mouse
was set on a custom-made stage under a two-photon
microscope (B-Scope, Thorlabs). Microglia located 50
m below the pial surface were imaged under awake
conditions at a wavelength of 920 nm. The laser power
was adjusted to 12 mW at the preparation (Hines et al.,
2009; Wake et al., 2009; Pfeiffer et al., 2016). Depth
stacks (24–26 slices, 2 m z interval, 512  512 pixels
corresponding to 101 101 m2 or 201 201 m2) were
acquired every 60 s.
Analysis
Iba1 IHC image analysis
Confocal images were used for pixel intensity analysis.
Image stacks extending to 15 m thickness were col-
lapsed into 2D images by maximum intensity projection.
Pixel intensities were converted to z scores, and the
cumulative distribution was computed for each collapsed
2D image.
For soma size analysis, confocal image stacks (45–50
m thickness) were first filtered with a 3  3  3 median
filter. The resultant image stacks were collapsed into 2D
images by maximum intensity projection. To correct for
uneven background, the rolling ball method with a radius
of 30 pixels was used for background subtraction. There-
after, the images were subjected to a 3  3 2D median
filter followed by binarization with Yen’s thresholding
method (ImageJ, National Institutes of Health) for soma
extraction. In some cases, manual adjustments of thresh-
old were needed. Extracted somata were approximated
to ellipses. Following these automated procedures in Im-
ageJ, extracted somata were validated by manual inspec-
tion. The median of microglial soma size distribution from
each mouse was taken as a data point for statistical
comparisons.
TH image analysis
The efficacy of DSP4 was evaluated by calculating the
mean intensity of posterior cortical layer 1 TH-positive
(TH) innervation using ImageJ. Briefly, sagittal brain sec-
tion images (60 m thickness) were acquired by a Key-
ence microscope (BZ-X710; 0.37 m pixel size). Ten to 12
contiguous regions of interest (ROIs; 100  100 m each)
were allocated to occupy layer 1. A background intensity
value was calculated from a neighboring parenchymal
area that does not contain TH axons. The mean TH
signal intensity of each ROI was computed as the mean
pixel intensity minus the background intensity.
Microglial motility assessment
Quantification of microglial surveillance was performed
using custom-written ImageJ and MATLAB programs
(MathWorks). The maximum intensity projection image
was computed for each time point of xyzt image stack.
The resultant xyt image stack was registered for xy motion
correction. Next, each slice of the xyt stack was pro-
cessed by the ImageJ “Subtract Background” plugin to
subtract smooth continuous background with a ball size
of 30 pixels. Thereafter, images were treated with a 2D 3
 3 median filter. After this preprocessing, rectangular
areas containing the morphologic extent of single micro-
glia were extracted as separate image stacks. These cell-
wise image stacks were then binarized with a single
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threshold determined by Li’s Minimum Cross Entropy
method (ImageJ). Noise reduction was then performed by
a cycle of erosion and dilation. The normalized surveil-
lance area at time t was calculated as the number of pixels
that were occupied by the microglia at least once since
the beginning of imaging until a given time t, divided by
the number of pixels occupied by the microglia at the
beginning. Normalized surveillance area is therefore a
monotonically increasing function of time (see Fig. 6C,D,
example). The surveillance index is defined as the ratio of
normalized surveillance areas of a microglia in two differ-
ent sessions [e.g., control (“Before”) vs post-tDCS (“Af-
ter”)].
Statistical analyses
Statistical analyses were performed using Igor Pro
(WaveMetrics). Student’s paired t tests and Wilcoxon-
Mann–Whitney rank sum tests were used for the compar-
ison of two sample populations with matched data and
unmatched data, respectively, unless otherwise noted.
Data are expressed as the mean 	 SEM, and p values
0.05 were considered statistically significant. Statistical
values are reported in Table 1.
Results
First, we confirmed tDCS-induced cortex-wide Ca2
elevations (Monai et al., 2016) in the present setting using
G7NG817 transgenic mice that express the G-CaMP7
Ca2 sensor in astrocytes and a subpopulation of neu-
rons. Mice had been acclimatized to be rigidly fixed to a
head-restraint platform, where tDCS (0.1 mA, 10 min) and
transcranial fluorescence imaging were performed (Fig.
1A,B; see Materials and Methods). Cortical Ca2 signals
elevated immediately after the passage of the DC current.
The peak amplitude of the G-CaMP7 response measured
3 mm anterior to the anodal position was 39.7 	 4.1%
(Fig. 1C; N  4 mice), showing that tDCS-induced Ca2
elevation is observable with the head chamber-ring con-
figuration. Notably, tDCS-induced Ca2 elevations were
not observed in isoflurane-anesthetized mice (Extended
Data Fig. 1-1). Having demonstrated the effectiveness of
tDCS, we used C57BL/6 mice to investigate microglial
morphology after tDCS by Iba1 IHC. Mice were killed
either 30 min or 3 h after tDCS for perfusion fixation.
Iba1 IHC patterns are affected by tDCS in awake
mice
Iba1 IHC visualized highly ramified microglial morphol-
ogy throughout brain slices of sham-operated, LPS-
treated, and tDCS mice (Fig. 2A,B,I,J). To investigate the
impact of tDCS on the wide-field appearance of Iba1 IHC,
we computed the pixel intensity distribution, which is a
proxy of global morphologic changes. We analyzed layer
2 and 3 of the visual cortex located below the anode,
since a previous study demonstrated that tDCS-mediated
plasticity occurs in these layers (Monai et al., 2016). Pixel
intensities were converted to z scores with which the
cumulative distributions were plotted. We compared head
ring-implanted, unrestrained control mice (Ctl group) with
head ring-implanted, acclimatized, 25 min head-
restrained mice (Sham group) to evaluate the possible
effects of head restraint. In Figure 2C, we demonstrate
that cumulative pixel intensity distribution is similar be-
tween the Ctl and Sham groups, whereas the pixel inten-
sity distribution shifted significantly in mice with reactive
microglia caused by LPS. These results suggest that the
head-restraining procedure in acclimatized mice does not
cause reactivity in cortical microglia.
Next, we compared tDCS and sham-treated mice. The
combination of two conditions [isoflurane-anesthetized
(isofl) or awake] and two time points (30 min and 3 h after
tDCS) were investigated (Fig. 2D–G). Pixel intensity distri-
bution was similar between sham and tDCS for isofl 30
min, isofl 3 h, and awake 30 min experiments; however,
the awake 3 h tDCS data exhibited a visible deviation from
the sham group (Fig. 2G). This deviation was caused by a
higher proportion of pixels at the high-intensity end. For
instance, tDCS had a relatively large presence of pixels
that had a z score 0.6 (21.2 	 1.6% vs 18.2 	 1.4%; p
 1.7e-5, t test). Moreover, a high-intensity cluster that
has a z score 2 was apparent in the pixel intensity
histogram (Fig. 2H). Consistent with this observation,
thresholding with z  2 preserved more microglial struc-
tures in awake 3 h tDCS images than the sham counter-
part (Fig. 2I,J). While the cumulative pixel intensity
histogram of awake 3 h tDCS deviated in the same direc-
tion as LPS, microglial morphology appeared normal with
fine ramified processes throughout the extent of the cor-
Table 1: Statistical table
　 Sample number: cells (animals) Test type p Value Power
a Sham: 334(7), Ctl: 315(7) Mann–Whitney Wilcoxon rank sum test 0.1 　
b Sham: 315(7), tDCS: 314(7) Mann–Whitney Wilcoxon rank sum test 0.16 　
c Sham: 309(7), tDCS: 301(7) Mann–Whitney Wilcoxon rank sum test 0.017 　
d Sham: 278(6), tDCS: 296(7) Mann–Whitney Wilcoxon rank sum test 0.95 　
e Sham: 285(7), tDCS: 319(7) Mann–Whitney Wilcoxon rank sum test 0.073 　
f Sham: 238(6), tDCS: 356(7) Mann–Whitney Wilcoxon rank sum test 0.73 　
g Sham: 274(7), tDCS: 310(7) Mann–Whitney Wilcoxon rank sum test 0.8 　
h Sham: 266(6), tDCS: 282(6) Mann–Whitney Wilcoxon rank sum test 0.48 　
i Sham: 13(8) Paired t test 0.82 0.055
j tDCS: 11(8) Paired t test 0.014 0.77
k Sham: 13(8), tDCS: 11(8) Mann–Whitney Wilcoxon rank sum test 0.006 　
l Sham: 11(3), tDCS: 9(2) Mann–Whitney Wilcoxon rank sum test 0.015 　
m Sham: 9(3), tDCS: 12(3) Mann–Whitney Wilcoxon rank sum test 0.023 　
p  0.05, p  0.03, p  0.01
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tex in all tDCS experiments. Thus, tDCS does not appear
to cause inflammatory responses.
tDCS enlarges microglial somata in awake mice
While the z score-based pixel intensity distribution anal-
ysis detected changes in the global appearance of im-
ages, it falls short of providing information on specific
aspects of morphologic alterations. Microglial soma size
has been reported to be sensitive to brain environmental
changes (Kongsui et al., 2015). Therefore, we measured
microglial soma size from Iba1 IHC images (Fig. 3A–C;
see Materials and Methods). First, we compared the me-
dian microglial soma size of individual animals (43 cells
per mouse on average) for unrestrained control and head-
restrained sham groups as we did in Figure 2C. Figure 3D
indicates that microglia soma sizes are similar between
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the control and sham groups (Ctl group: 45.4 	 1.0 m2,
7 mice; Sham group: 43.4 	 1.0 m2, 7 mice; p  0.16b,
Mann–Whitney Wilcoxon test), suggesting that the micro-
glial soma size of the Sham group serves as a valid control
for tDCS experiments.
Soma size did not differ significantly between the
awake 30 min tDCS and Sham groups (Sham group: 41.5
	 0.92 m2, 7 mice; tDCS group: 41.9	 0.9 m2, 7 mice;
Fig. 3E; p  1.0a). In awake 3 h experiments, soma size
was significantly larger in the tDCS group (p  0.017e;
Sham group: 43.4	 1.0 m2, 7 mice; tDCS group: 47.5	
1.2 m2, 7 mice; Fig. 3E). On the other hand, soma size
did not differ significantly when tDCS was performed on
isoflurane-anesthetized mice (3 h group: p  0.95f, Sham
group: 43.7	 1.8 m2, 6 mice; vs tDCS group: 43.2	 1.3
m2, 7 mice; Fig. 3F). These results were consistent with
the pixel intensity distribution analysis (Fig. 2) and suggest
that isoflurane anesthesia hampers tDCS-induced micro-
glial soma enlargement.
tDCS-induced microglial soma enlargement is
dependent on adrenergic receptors
Recent human and animal studies have implicated the
involvement of noradrenaline in tDCS (Monai et al., 2016;
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Comparison of microglial soma size in awake mice with/without tDCS treatment at different time points (30 min or 3 h) after tDCS.
Microglial soma size was larger in the tDCS group in the awake 3 h experiment (p  0.017c, Mann–Whitney Wilcoxon rank sum test).
Each group contains seven mice. F, Microglial soma size comparison in isoflurane-anesthetized mice (Isofl-3hr). p  0.03, N.S. not
significant.
New Research 7 of 12
September/October 2019, 6(5) ENEURO.0204-19.2019 eNeuro.org
Kuo et al., 2017; Monai and Hirase, 2018; Souza et al.,
2018). To examine the possible contribution of noradren-
aline to tDCS-induced microglia soma size, we ablated
noradrenergic cells in the locus ceruleus using the neuro-
toxin DSP4 (Bekar et al., 2008), which was confirmed by
TH staining in the sensory cortex (Fig. 4A,B). Following
noradrenergic neuron ablation, we performed tDCS using
the awake 3 h protocol. As a result, DSP4-treated mice
did not show a microglial soma enlargement after tDCS
(Fig. 4C; Sham group: 47.3 	 0.6 m2, 7 mice; tDCS
group: 44.5 	 1.1 m2, 7 mice; p  0.073e).
Since astrocytes exhibit profound 1-adrenergic recep-
tor (A1AR)-mediated Ca2 elevations by tDCS (Monai
et al., 2016), astrocytic Ca2 signaling possibly plays a
role in the microglial soma enlargement via an intercellular
communication. To examine this possibility, we used
IP3R2 knock-out mice in which Gq GPCR (e.g., A1AR)-
activated intracellular Ca2 elevation is diminished in as-
trocytes. Awake 3 h tDCS did not result in significant
microglial soma size changes in IP3R2 KO mice (p 0.73
f;
Sham group: 44.6	 1.4 m2, 6 mice; tDCS group: 44.4	
0.56 m2, 7 mice; Fig. 5A). We next examined the involve-
ment of A1AR using the specific antagonist prazosin in
wild-type C57BL/6J mice. Similar to IP3R2 KO mice,
prazosin-treated mice did not display tDCS-induced mi-
croglial soma enlargement compared with the Sham con-
trol group that also received the antagonist pretreatment
(p  0.8  g; Sham group: 42.6 	 0.9 m2, 7 mice; tDCS
group: 42.3 	 0.7 m2, 7 mice; Fig. 5B). These results
suggest that tDCS-triggered noradrenaline release affects
microglial soma enlargement via A1AR activation and the
downstream astrocytic IP3R2-dependent Ca
2 signaling
pathway.
Furthermore, we asked whether activation of -ad-
renergic receptors is also involved. In particular, microglia
are known for high levels of 2-adrenergic receptor
(B2AR) expression (Tanaka et al., 2002, Gyoneva and
Traynelis, 2013). Accordingly, mice were pretreated with
ICI181551, a selective B2AR blocker, and soma sizes
were compared. In the ICI181551 group, tDCS-induced
soma size enlargement was not observed (p  0.48h;
Sham group: 45.9	 0.8 m2, 6 mice; tDCS group: 45.2	
1.7 m2, 6 mice; Fig. 5C). These results are indicative of
noradrenergic involvement in tDCS-induced microglial
changes and suggest that both A1ARs and B2BRs are
involved in tDCS-induced microglial soma enlargement.
tDCS decreases microglial surveillance area in vivo
One of the striking features of microglia is the motility of
their ramified processes. Here, we directly examined the
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morphologic dynamics of individual microglia in the cor-
tex of awake mice using a two-photon microscope (Fig.
6A). We used the Iba1-EGFP mouse, in which EGFP is
exclusively expressed in microglia (Hirasawa et al., 2005).
We confirmed that microglia showed surveillance activi-
ties by continual extension and retraction of their pro-
cesses in all directions (Davalos et al., 2005; Nimmerjahn
et al., 2005). For example, the overlay of 60 min imaging
resulted in an extensive coverage of the area within 60
m from the soma, while the soma position remained
unmoved (Fig. 6C). We defined normalized surveillance
area as the proportion of cumulative microglia-occupied
area at a given time relative to a start time (Fig. 6D). To
check whether laser scanning has an impact on microglial
morphology, we compared the occupied area of each
monitored microglia at the beginnings of Before and After
imaging sessions of the Sham-treated group (Fig. 6E). We
found no significant difference, suggesting that the effect
of laser irradiation on microglial morphologic dynamics is
negligible.
While the evolution of a normalized surveillance area
varied considerably among individual microglia, the aver-
age trace converged to a gradually decelerating curve
(Fig. 6F). The mean surveillance area after 60 min did not
differ significantly between before and after sham stimu-
lation. Remarkably, the mean surveillance area index
curve of tDCS mice (i.e., After session) is plotted lower
than the control condition (i.e., Before session). We as-
sessed the surveillance area change of individual micro-
glia by taking the ratio of the surveillance area indices
during Before and After sessions, demonstrating a signif-
icant decrease of surveillance area by tDCS (t  40 min,
p  0.014j, paired t test; Fig. 6G).
Furthermore, we addressed whether noradrenergic sig-
naling is involved in this tDCS-induced microglial surveil-
lance reduction by prazosin or ICI181551 pretreatment in
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awake mice (Fig. 7A). As a reference, we computed the
surveillance index comparing Before and After sessions at
40 min after the start of respective sessions. As expected
from the previous analysis (Fig. 6G), the surveillance index
of tDCS experiments was significantly reduced (Fig. 7A).
Prazosin-treated mice showed a similar significant reduc-
tion of surveillance index after tDCS (Fig. 7B). By contrast,
ICI181551 treatment abolished tDCS-induced reduction
of microglia surveillance, and a trend for increased sur-
veillance was apparent (Fig. 7C). These results point to a
significant role of the B2AR in the inhibition of microglial
surveillance activity after tDCS.
Discussion
The present experiments report that tDCS induces sub-
tle, but significant, alterations of Iba1 distribution and
microglial motility in the cerebral cortex in awake mice.
Furthermore, these alterations were dependent on (nor-
)adrenergic receptors, which is in line with the results of
an earlier study that described tDCS-induced A1AR-
dependent astrocytic Ca2 surges (Monai et al., 2016).
Notably, while astrocytic Ca2 responses occur during
tDCS, morphologic alterations of microglia occurred after
a few hours.
We demonstrated that the microglial soma is enlarged
after tDCS. Remarkably, the soma enlargement occurs
only in awake mice. It is well established that microglial
morphology is radically altered by LPS-induced inflamma-
tion (Kondo et al., 2011; Kozlowski and Weimer, 2012;
Kongsui et al., 2015). LPS-induced microglial alterations
are obvious even with a low dosage of 100 g/kg,
whereby 20% soma enlargement has been reported in
the prefrontal cortex (Kongsui et al., 2015). The tDCS-
induced microglial soma enlargement of a mere several
percentage points in the current study is relatively mod-
est. Moreover, no obvious change was detected in rami-
fied processes. As general anesthesia compromises
astrocytic Ca2 activation, in particular noradrenergically
driven large-scale and synchronized Ca2 surges (Thrane
et al., 2012; Ding et al., 2013), microglial changes by tDCS
conceivably depend on the elevated noradrenergic tone
during awake states. On the other hand, some studies
have reported significant changes in anesthetized mice
that underwent tDCS. For instance, one study reported
that enhancements of GFAP and brain-derived neu-
rotrophic factor (BDNF) in anesthesia changed gene ex-
pression (de Souza Nicolau et al., 2018). Another study
showed long-lasting antidepressive behavioral effects
(Peanlikhit et al., 2017). However, these studies used
stronger stimulation in terms of stimulus current, duration,
and/or frequency. Moreover, the anesthesia condition
used in the current study is deeper than that in the study
by Peanlikhit et al. (2017). Considering the lack of astro-
cytic Ca2 surges in this condition (Extended Data Fig.
1-1), our results support the involvement of volume-
transmitted neuromodulators in tDCS.
A few studies have examined cortical microglia after
tDCS. For instance, Rueger et al. (2012) reported that
multisession tDCS of 5–10 d induced a mild sign of mi-
croglial activation as observed by an upregulation of Iba1
immunohistochemical signals. The current density used in
the study by Rueger et al. (2012) was 150 A/m2,
whereas that used in the current study is 30 A/m2.
Considering the study by Gellner et al. (2016), which
reported a microglial activation threshold of 30–50 A/m2
with light isoflurane anesthesia, it is conceivable that our
experiments were performed in near-threshold condi-
tions. The tDCS-induced microglial soma enlargement
and Iba1 signal intensity distribution shift are different
from the microglial morphologic alterations reported in a
rodent model of electroconvulsive therapy (ECT), in which
obvious reductions in process ramification and Iba1 ex-
pression occur (Jinno and Kosaka, 2008). The pro-
nounced alterations of microglia by ECT are most likely
caused by the high-intensity electric stimulation that in-
duces seizures. By contrast, cortical neuronal discharge
activity remains undisturbed by tDCS (Monai et al., 2016;
Vöröslakos et al., 2018).
We find that tDCS-induced soma enlargement is de-
pendent on noradrenergic signaling. Moreover, the pra-
zosin and IP3R2-KO mouse (which lacks astrocytic Ca
2
surges) experiments suggest a key mechanism linked to
A1AR activation. The previous reports of relative abun-
dance of A1ARs in astrocytes over microglia (Hertz et al.,
2010; Zhang et al., 2014) and A1AR-dependent tDCS-
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induced astrocytic Ca2 surges (Monai et al., 2016) sup-
port the idea that astrocytic activation exerts effects on
microglia. While this is intriguing, neither the prazosin nor
the IP3R2 KO mouse experiment is cell type specific;
therefore, it is possible that direct noradrenergic activa-
tion of microglia causes soma enlargement. Indeed, B2AR
inhibition by ICI181551 also disrupted microglial somatic
enlargement. Functional and transcriptomic evidence un-
derwrites the enriched expression of B2ARs in microglia
(Tanaka et al., 2002; Gyoneva and Traynelis, 2013; Zhang
et al., 2014).
By imaging microglial morphology in awake mice, we
found that tDCS attenuates microglial motility. This effect
was also dependent on B2ARs, but not on A1ARs. The
inhibitory effect of microglial B2ARs on motility is consis-
tent with the in vitro observation by Gyoneva and Trayne-
lis (2013) and recent in vivo observations in awake mice
(Liu et al., 2019; Stowell et al., 2019). It is tempting to
speculate that the brake on microglial surveillance creates
an opportunity for relevant synapses to establish an initial
stage of synaptic plasticity. Microglia have been demon-
strated to be a source for BDNF (Parkhurst et al., 2013), a
pivotal neurotrophin for synaptic plasticity and neurogen-
esis. Interestingly, tDCS upregulates Bdnf (de Souza Ni-
colau et al., 2018), promotes BDNF-dependent synaptic
plasticity (Fritsch et al., 2010), and causes epigenetic
modification to Bdnf genomic regions (Podda et al., 2016).
It remains to be shown whether BDNF synthesis is pro-
moted by (nor)adrenergic activation as is reported in as-
trocytes (Juri et al., 2008). In addition to astrocyte–
neuron interactions (Monai and Hirase, 2016; Cocco et al.,
2018), our results advocate for the inclusion of microglia
as a functional component of the tDCS mechanism via
adrenergic receptor activation.
One of the limitations of the current study is the lack of
microglia-specific molecular manipulations. While it re-
mains undetermined whether the microglial changes ob-
served in this study have causal roles for positive
outcomes of tDCS, several groups have consistently re-
ported inflammation-associated microglial soma enlarge-
ment (Chen et al., 2012; Kozlowski et al., 2012; Kongsui
et al., 2015). Brain inflammation activates microglia and
leads to the production of proinflammatory molecules
such as TNF-, IL-1, and IL-6 (Hanisch, 2002). It is
possible that these cytokines are involved in the synaptic
plasticity induced by tDCS. For instance, it has been
demonstrated that the glial TNF- has a pivotal role in the
regulation of homeostatic synaptic plasticity (Stellwagen
and Malenka, 2006). Future studies should address the
causal relationship, for instance by microglial B2AR
knock-out mice combined with tDCS and behavioral per-
formance.
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